Canada markets closed

WuXi Biologics (Cayman) Inc. (2269.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
18.460-0.440 (-2.33%)
At close: 04:08PM HKT
Currency in HKD

Valuation Measures4

Market Cap (intraday) 78.92B
Enterprise Value 75.06B
Trailing P/E 18.09
Forward P/E 14.35
PEG Ratio (5 yr expected) 0.62
Price/Sales (ttm)4.52
Price/Book (mrq)1.90
Enterprise Value/Revenue 4.53
Enterprise Value/EBITDA 14.78

Trading Information

Stock Price History

Beta (5Y Monthly) 0.68
52-Week Change 3-67.58%
S&P500 52-Week Change 328.52%
52 Week High 359.950
52 Week Low 314.700
50-Day Moving Average 324.377
200-Day Moving Average 338.213

Share Statistics

Avg Vol (3 month) 353.4M
Avg Vol (10 day) 342.91M
Shares Outstanding 54.18B
Implied Shares Outstanding 64.35B
Float 83.64B
% Held by Insiders 114.16%
% Held by Institutions 147.98%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 23:1
Last Split Date 3Nov 16, 2020

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023


Profit Margin 25.08%
Operating Margin (ttm)27.11%

Management Effectiveness

Return on Assets (ttm)5.23%
Return on Equity (ttm)11.45%

Income Statement

Revenue (ttm)16.55B
Revenue Per Share (ttm)3.98
Quarterly Revenue Growth (yoy)17.80%
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)4.15B
Diluted EPS (ttm)1.050
Quarterly Earnings Growth (yoy)-10.60%

Balance Sheet

Total Cash (mrq)8.69B
Total Cash Per Share (mrq)2.05
Total Debt (mrq)5.34B
Total Debt/Equity (mrq)13.67%
Current Ratio (mrq)2.20
Book Value Per Share (mrq)8.88

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A